Indivior PLC | Key People and Executives
Shaun Thaxter
Chief Executive Officer & Executive Director
Mark Crossley
Chief Financial Officer & Executive Director
Tatjana Anni Hilde May
Independent Non-Executive Director
Daniel Tassé
Senior Independent Non-Executive Director
Lizabeth Herbst Zlatkus
Independent Non-Executive Director
Lorna Parker
Independent Non-Executive Director
Christian S. Schade
Independent Non-Executive Director
Daniel J. Phelan
Independent Non-Executive Director
A. Thomas McLellan
Independent Non-Executive Director
Yvonne Greenstreet
Independent Non-Executive Director
Shaun Thaxter
Chief Executive Officer & Executive Director
Mark Crossley
Chief Financial Officer & Executive Director
Christian Heidbreder
Chief Scientific Officer
Ponni Subbiah
Chief Medical Officer
Ingo Elfering
Chief Information Officer
Susan Learned
Senior Vice President-Global Clinical Development
Frank Stier
Chief Supply Officer
Richard Simkin
Chief Commercial Officer
Michael R. Clarke
Vice President-Corporate Compliance
Jason F. Thompson
Vice President-Investor Relations
Debby Betz
Chief Corporate Affairs & Communications Officer
Jon Fogle
Chief Human Resources Officer
Javier Rodriguez
Chief Legal Officer
Tatjana Anni Hilde May
Independent Non-Executive Director
Daniel Tassé
Senior Independent Non-Executive Director
Lizabeth Herbst Zlatkus
Independent Non-Executive Director
Lorna Parker
Independent Non-Executive Director
Christian S. Schade
Independent Non-Executive Director
Daniel J. Phelan
Independent Non-Executive Director
A. Thomas McLellan
Independent Non-Executive Director
Yvonne L. Greenstreet
Independent Non-Executive Director
| Address |
103-105 Bath Road
Slough Berkshire SL1 3UH
United Kingdom
|
|
Employees
|
- |
| Website |
http://indivior.com/ |
| Updated |
07/08/2019 |
| Indivior PLC is a holding company, which engages in the manufacture and distribution of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, Subutex Tablet, and Sublocade Injection. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom. |
